The Indian edtech Market is estimated to be valued at US$ 1.6 Billion in 2022 and is expected to exhibit a CAGR of 16.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Edtech refers to the education technology sector which provides online learning platforms and solutions. It offers E-learning, mobile learning and educational enterprise resource planning solutions to help enhance teaching-learning processes. Edtech products have advantages such as improved accessibility, flexibility, affordability and interactive learning experiences for students. There is an increasing need for such digital learning platforms in India due to the growing internet and smartphone penetration.
Market key trends:
One of the major trends driving the Indian edtech market is increased adoption of online learning post-COVID. During the pandemic induced lockdowns, traditional classroom learning was disrupted. This led to a surge in the demand for edtech solutions as online learning became the new normal. Many students and educational institutes started relying more on virtual classrooms, e-learning apps and video conferencing tools for education continuity. Various online learning startups witnessed significant growth in their user base during this period. Increased internet penetration in the country is also supporting the uptake of digital education platforms going forward.
Porter's Analysis
Threat of new entrants: New companies need significant capital investment for facilities, manufacturing equipment, and R&D. Patents also act as entry barrier.
Bargaining power of buyers: The stem cell assay market has several buyers like pharmaceutical and biotechnology companies, academic & research institutions. Their bargaining power is moderate.
Bargaining power of suppliers: The stem cell assay market has several suppliers providing different types of kits, reagents and instruments. Their bargaining power is moderate.
Threat of new substitutes: There is no major threat of substitutes as stem cell assays have wide applications in scientific research.
Competitive rivalry: The global stem cell assay market is highly competitive with presence of large multinational companies.
SWOT Analysis
Strength: Wide applications in drug discovery, personalized medicine and regenerative medicine. Growing focus on stem cell-based research.
Weakness: Ethical issues related to human embryonic stem cells. High costs associated with stem cell research.
Opportunity: Emerging economies offer growth opportunities. Increasing stem cell banking facilities.
Threats: Stringent regulations for stem cell research. Challenges in commercialization of stem cell-based therapies.
Key Takeaways
The global Stem Cell Assay Market Share is expected to witness high growth, exhibiting CAGR of 16.5% over the forecast period, due to increasing funding for stem cell research from both private and public organizations.
Regionally, North America dominates the stem cell assay market and is estimated to account for over 40% of the global market revenue in 2023, owing to presence of large biopharma companies and increasing adoption of personalized medicine in the region. Asia Pacific is anticipated to witness fastest growth during the forecast period, driven by expanding stem cell research infrastructure and growing healthcare expenditure in countries such as China and India.
Key players operating in the stem cell assay market are Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International. Major players are focused on new product launches and mergers & acquisitions to strengthen their market position.
Read More,
https://www.newsstatix.com/stem-cell-assay-market-trends-size-and-share-analysis/
Comments
0 comment